Award
National Cancer Institute 5R01CA276683-04
Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer
Recipient
Not specified
Award Amount
$610,112.00
Ceiling
$610,112.00
Awarded
February 26, 2026
Identifier
5R01CA276683-04
NIH grant awarded by the National Cancer Institute for research to develop potent and non-toxic rexinoids aimed at preventing non-melanoma skin cancer, including testing in murine models.
Description
This is a NIH grant opportunity for research on rexinoids to prevent non-melanoma skin cancer, with a focus on developing analogs with enhanced potency and pharmacokinetics, and testing in murine models.